Navigator Holdings Ltd. ( NYSE: NVGS) Q4 2024 Earnings Conference Call March 12, 2025 10:00 AM ET Randy Giveans - EVP, IR & Business Development Mads Peter Zacho - CEO Gary Chapman - CFO Oeyvind ...

November 15, 2024 Nordic ... Bank flags credit risks as returns to profit in third quarter Deutsche Bank has raised its forecast for bad loans against the backdrop of a weak German economy ...

D: Neither pouring rain, strong winds, war in Europe nor all the current international crises had managed to spoil the FIS ...

Saranac Lake High School Nordic ski coach and band director ... Race Team crosses the 3P finish line with a American, German and Mexican flag. (Enterprise photo — Aaron Marbone) ...

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...

COPENHAGEN, Denmark, February 25, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced a strategic partnership with Biological E. Limited (BE) to expand access to Bavarian Nordic’s ...

About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox ...

COPENHAGEN, Denmark, February 28, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA ® for active ...

Biological E has partnered strategically with Bavarian Nordic to expand access to Bavarian Nordic’s Chikungunya vaccine in low- and middle-income countries (LMIC). The partnership comprises a ...

COPENHAGEN, Denmark, March 5, 2025 – Bavarian Nordic A/S (OMX: BAVA) today published its Annual Report for 2024. The consolidated, audited results were in line with the preliminary results ...

Johnson & Johnson has halved the size of its collaboration with Bavarian Nordic on vaccine development, jettisoning its stake in shots targeting human papillomavirus (HPV) and hepatitis B virus (HBV).

COPENHAGEN, Denmark, March 7, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has validated the marketing authorization ...